Commonwealth Equity Services
NXTM

Commonwealth Equity Services’s NxStage Medical Inc. NXTM Stock Holding History

Commonwealth Equity Services’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,353
Closed -$373K – 2897
2018
Q2 		$373K Buy
+13,353
New +$358K ﹤0.01% 1953

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Commonwealth Equity Services's NXTM Position: Q3 2018 in Review

Commonwealth Equity Services sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 13,353 shares — an estimated $373K sold.

Commonwealth Equity Services first reported a position in NXTM in Q2 2018 and held it in 1 quarter. The position peaked at $373K in Q2 2018. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • Commonwealth Equity Services reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • Commonwealth Equity Services sold 13,353 NxStage Medical Inc. shares in Q3 2018, an estimated $373K.
  • Commonwealth Equity Services first reported a position in NxStage Medical Inc. in Q2 2018 and held it in 1 quarter.
  • Commonwealth Equity Services's NxStage Medical Inc. position peaked at $373K in Q2 2018.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on Commonwealth Equity Services's 13F filing for Q3 2018, filed 6 Nov 2018.